Allergy Sinus, Lil Drug Store Tablet
NDC Package 66715-9927-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Allergy Sinus, Lil Drug Store (acetaminophen, phenylephrine hydrochloride, chlorpheniramine maleate) tablets is directionsdo not take more than directedadults and children 12 years and overtake 2 tablets every 4 to 6 hours as neededdo not take more than 12 tablets in 24 hours or as directed by a doctorchildren under 12 years of ageask a doctor. This formulation utilizes a tablet delivery system. Marketed by Lil' Drug Store Products, Inc., this product is identified by NDC 66715-9927 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
66715-9927-3
Package Description
3 POUCH in 1 CARTON / 2 TABLET in 1 POUCH
Product Code
66715-9927
11-Digit Billing Format
66715992703
RxNorm Crosswalk
  • RxCUI: 1046781 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1046781 - acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1046781 - APAP 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Allergy Sinus, Lil Drug Store
Non-Proprietary Name
Acetaminophen, Phenylephrine Hydrochloride, Chlorpheniramine Maleate
Substance Name
Acetaminophen; Chlorpheniramine Maleate; Phenylephrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Directionsdo not take more than directedadults and children 12 years and overtake 2 tablets every 4 to 6 hours as neededdo not take more than 12 tablets in 24 hours or as directed by a doctorchildren under 12 years of ageask a doctor

Regulatory & Marketing

Labeler Name
Lil' Drug Store Products, Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-08-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66715-9927-3 identifies a specific commercial package of 3 pouch in 1 carton / 2 tablet in 1 pouch of Allergy Sinus, Lil Drug Store, a human over the counter drug labeled by Lil' Drug Store Products, Inc.. This tablet is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lil' Drug Store Products, Inc. on February 08, 2011. The current certification is valid through December 31, 2026.

How is this Lil' Drug Store Products, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66715992703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
66715-9927-3
11-Digit CMS (5-4-2)
66715-9927-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.